Application 074930
- Type
- ANDA
- Sponsor
- FRESENIUS KABI USA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ACYCLOVIR SODIUM | ACYCLOVIR SODIUM | INJECTABLE;INJECTION | EQ 50MG BASE/ML | No | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 63323-325 | Acyclovir | ACYCLOVIR SODIUM | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-325 | Acyclovir | ACYCLOVIR SODIUM | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-325 | Acyclovir | ACYCLOVIR SODIUM | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-325 | Acyclovir | ACYCLOVIR SODIUM | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-325 | Acyclovir | ACYCLOVIR SODIUM | Fresenius Kabi USA, LLC | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 42900 | ORIG | 1998-05-13 |
| 8466 | ORIG | 1998-05-13 |